Erste Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-486,374
| Closed | -$89.5M | – | 634 |
|
|
2025
Q4 | $89.5M | Sell |
486,374
-4,950
| -1% | -$868K | 0.75% | 27 |
|
|
2025
Q3 | $72.8M | Sell |
491,324
-14,657
| -3% | -$2.22M | 0.7% | 31 |
|
|
2025
Q2 | $70.7M | Buy |
505,981
+25,657
| +5% | +$3.6M | 0.59% | 36 |
|
|
2025
Q1 | $70.7M | Hold |
480,324
| – | – | 0.91% | 25 |
|
|
2024
Q4 | $63.2M | Buy |
480,324
+15,000
| +3% | +$2.1M | 0.77% | 31 |
|
|
2024
Q3 | $72.4M | Sell |
465,324
-10,000
| -2% | -$1.61M | 0.87% | 26 |
|
|
2024
Q2 | $74.2M | Sell |
475,324
-15,000
| -3% | -$2.26M | 0.98% | 21 |
|
|
2024
Q1 | $66.6M | Buy |
490,324
+60,500
| +14% | +$8.01M | 0.91% | 24 |
|
|
2023
Q4 | $57.9M | Sell |
429,824
-30,000
| -7% | -$3.9M | 0.85% | 27 |
|
|
2023
Q3 | $62.2M | Buy |
459,824
+78,000
| +20% | +$10.7M | 1.07% | 14 |
|
|
2023
Q2 | $54.5M | Buy |
381,824
+300,000
| +367% | +$44.1M | 0.96% | 17 |
|
|
2023
Q1 | $11.3M | Hold |
81,824
| – | – | 0.22% | 121 |
|
|
2022
Q4 | $11.1M | Buy |
81,824
+6,100
| +8% | +$765K | 0.24% | 117 |
|
|
2022
Q3 | $8.32M | Hold |
75,724
| – | – | 0.19% | 143 |
|
|
2022
Q2 | $10.2M | Buy |
75,724
+8,000
| +12% | +$1.05M | 0.23% | 120 |
|
|
2022
Q1 | $9.09M | Buy |
67,724
+10,300
| +18% | +$1.24M | 0.17% | 150 |
|
|
2021
Q4 | $6.74M | Sell |
57,424
-25,750
| -31% | -$3.03M | 0.12% | 178 |
|
|
2021
Q3 | $9.93M | Buy |
83,174
+18,174
| +28% | +$2.12M | 0.2% | 134 |
|
|
2021
Q2 | $7.82M | Hold |
65,000
| – | – | 0.16% | 153 |
|
|
2021
Q1 | $6.5M | Hold |
65,000
| – | – | 0.16% | 158 |
|
|
2020
Q4 | $6.49M | Buy |
+65,000
| New | +$6.88M | 0.18% | 145 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 472 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 453 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 438 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 443 |
|
Other funds holding AZN
IA
VCM
VAM